Davide Campari-Milano NV (EPA: CPR) reports positive organic net revenue growth year-on-year in its 9-month 2026 trading update (publication ca. 10 November 2026), confirmed by Campari IR or Bloomberg by 12 November 2026
Pending
✦ AI-generated prediction
Published on 18. September 2026
·
Predicted for 10. November 2026
·
Based on: Historical Cycle
Campari delivered +2.9% organic growth in Q1 2026 and +2.7% in H1 2026, maintained full-year guidance of ~3% organic growth, and even raised its EBIT margin guidance — the fifth consecutive quarter of positive organic growth. Q3 2026 is expected to show mild deceleration to +1–2% (premiumisation headwinds in Europe, normalisation of distillery fire one-offs); cumulative 9M growth of +2–3% organic would comfortably clear the threshold (>0%). Key risks: abrupt US consumer deterioration, soft China business. No prediction-market data available for Campari 9M; probability estimated at ~72% based on guidance and analyst consensus.
Data basis for this prediction
- Campari H1 2026: organisches Nettoumsatzwachstum +2,7 %, adj. EBIT 358 Mio. EUR, Marge 23,7 % (The Spirits Business / Gurufocus, Juli 2026)
- Campari Q1 2026: +2,9 % organisch, FY-Guidance ~3 % bestätigt (Campari Press Release / Investing.com, Mai 2026)
- Campari Earnings Call H1 2026: Fünfte Folge-Periode positives Wachstum, EBIT-Marge-Guidance angehoben (Gurufocus / Quartr.com, August 2026)
- Campari FY-Guidance ~3 % organisches Wachstum bestätigt nach H1-Ergebnissen (Campari Group IR, Juli 2026)
Verdict: Pending
This prediction is still open. It will be evaluated automatically against real-world sources after its due date.
🍾 Beverages
✦ AI
The international spirits industry is experiencing pronounced demand weakness: Brown-Forman reported a −1% organic net revenue decline for Q1 FY2027 (May–July 2026) — an already widespread trend. Diageo (open Cassandra forecast: H1 FY2026/27 decline), AB InBev, and Heineken show similar structural weaknesses. Pernod Ricard's key brands Jameson, Chivas Regal, and Martell are suffering from US destocking and China demand weakness — both effects already manifested in negative organic rates in FY2024/25 and FY2025/26. The Q1 FY2027 sales update is typically published mid-to-late October (historical anchor: Q1 FY2024/25 on October 17, 2024). No Polymarket market available; industry trend estimate: 68%.
🍾 Beverages
✦ AI
The global premium spirits market is in a sustained sales crisis: Diageo itself reported an organic net revenue decline of −2.0% for FY2025/26 (July 2025–June 2026) (volume −0.4%, price/mix effect −1.6%, Diageo Preliminary Results, July 2026). Peer Brown-Forman also recorded −1% organic in Q1 FY2027 (May–July 2026) (confirmed Cassandra hit, September 2, 2026). Pernod Ricard is also expected to show an organic decline in Q1 FY2026/27 per an open prediction. Common drivers: consumer restraint in the US (high rates at 3.75–4.00% after Fed hike), China slowdown in baijiu/whisky segment, premiumization backlash, and buyer substitution toward RTD products. The base effect (−2% in FY2026) could make H1 FY2026/27 mathematically easier to beat, but deteriorating conditions in the second half of 2026 still argue for continued negative organics.
🍾 Beverages
✦ AI
Rémy Cointreau returned to positive territory in full-year FY2025/26 with +0.2% organic revenue growth — after a disastrous -18.0% in FY2024/25. Crucially, the H1 FY2025/26 comparison period (April–September 2025) was still weak at -4.2% organic. This low base materially eases the path to positive organic growth in H1 FY2026/27. Supportive: US cognac destocking cycle largely complete, recovering premium spirits demand in select markets. Risks: China VIP demand remains subdued, APAC recovery slow. Countervailing signals: Pernod Ricard and LVMH Wines & Spirits are still forecast to decline organically on this platform. No Polymarket market available; self-assessed probability 60%.